Doug Fisher, Arnold Oronsky
Doug Fisher has joined Sera Prognostics as chief business officer. The company also has appointed Arnold Oronsky to its board. Fisher has been a partner at venture capital firm InterWest Partners and served on Sera's board starting in late 2011. Sera said that he has resigned as a director in connection to his joining the company's management team.
Oronsky is a general partner at InterWest and has investment experience in diagnostics and pharmaceutical companies, Sera said. Before joining InterWest, he was vice president of discovery research at Lederle Laboratories, a division of American Cyanamid.